Ec. Lasser et al., PRETREATMENT WITH CORTICOSTEROIDS TO PREVENT ADVERSE REACTIONS TO NONIONIC CONTRAST-MEDIA, American journal of roentgenology, 162(3), 1994, pp. 523-526
OBJECTIVE. The purpose of this study was to determine whether patients
receiving a two-dose corticosteroid regimen before IV injection of no
nionic contrast medium gain protection against adverse reactions to co
ntrast material. SUBJECTS AND METHODS. A randomized, blinded study inv
olving three institutions was initiated in 1988. Patients were divided
into two groups. One group received a 32-mg oral dose of methylpredni
solone administered 6-24 hr before and again 2 hr before injection of
contrast material. The other group received placebo tablets administer
ed in the same time periods. During a 3-year period, 1155 patients and
control subjects successfully completed the protocol. Demographic cha
racteristics, including histories of previous reactions and histories
of asthma or allergy, did not differ in the two groups. All signs and
symptoms that appeared after injection of contrast material were caref
ully recorded and graded according to an earlier scheme [1]. Patients,
control subjects, and all attending personnel were blinded regarding
the premedication. RESULTS. Corticosteroid pretreatment conferred prot
ection for overall reactions (1.7% vs 4.9%, p = .005) and grade I (mil
d) reactions (0.2% vs 1.9%, p = .004). Subjects receiving corticostero
ids also had fewer grade II (moderate) (p = .63) and grade III (severe
) (p = .11) reactions, but the total numbers involved were small, and
the differences were not significant. CONCLUSION. A rigidly controlled
study of the potential protective effects of a two-dose oral corticos
teroid regimen preceding IV injection of nonionic contrast medium indi
cates that corticosteroid pretreatment confers significant protection,
at least for overall reactions and grade I reactions.